Menu Back toHow to Share Individual Patient-Level Data Safely for Pharma Innovation

DIA 2021 Global Annual Meeting


How to Share Individual Patient-Level Data Safely for Pharma Innovation

Session Chair(s)

Niamh Catherine McGuinness

Niamh Catherine McGuinness

  • Clinical Trial Transparency Anonymization Expert
  • Privacy Analytics, Canada
Attendees will be presented with a fictional scenario and will learn about the different decisions which can determine the safety and defensibility of a patient-level data-sharing strategy. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.
Learning Objective : Recognize the importance of engaging in clinical data-sharing; Compare the various avenues through which clinical data can be shared; Identify statistical anonymization as an approach which can demonstrably protect patient privacy while preserving utility.